Know Diabetes by Heart™ Professional Education Podcast Series
Know Diabetes by Heart™ Professional Education Podcast Series
American Heart Association and American Diabetes Association
The American Heart Association and the American Diabetes Association are excited to announce a new podcast series for healthcare professionals. Know Diabetes by Heart™ Professional Education Podcast Series focuses on the link between cardiovascular disease (CVD) and type 2 diabetes (T2D). The series will consist of relevant cutting-edge topics such as up-to-date standards of care, guidelines and their implications for T2D and CVD, and approaches to shared decision making—among others. The American Heart Association’s and the American Diabetes Association's Know Diabetes by Heart Professional Education™ Podcast Series is brought to you by founding sponsor, Novo Nordisk, and national sponsor, Bayer.
2024 Episode 11 – Understanding ASCVD Progression in Patients with Type 2 Diabetes, and Strategies to Assess its Risk
Listen to Rodica Busui (Pop-Busui), MD, PhD, Neha J. Pagidipati, MD, MPH, and Jennifer B. Green, MD discuss ASCVD (atherosclerotic cardiovascular disease) progression in patients with type 2 diabetes, strategies to assess its risk, and the COORDINATE study.
Feb 1
33 min
2023 Episode 10 – Is Chronic Kidney Disease in Type 2 Diabetes Preventable?
Listen to Michael J. Blaha, MD, MPH and Richard E. Pratley, MD discuss the link between type 2 diabetes and chronic kidney disease (CKD) as well as taking a multidisciplinary approach to managing people with type 2 diabetes at risk for chronic kidney disease progression.
Oct 13, 2023
33 min
2023 Episode 9 – Cultural Considerations in Type 2 Diabetes and Cardiovascular Disease
Listen to Traci Thompson, MD, MBA, CPE, Latha Palaniappan, MD, MS, and Alka Kanaya, MD discuss racial and ethnic considerations when screening and managing patients with type 2 diabetes (T2D) and cardiovascular disease (CVD), as well as related health care disparities and barriers in managing and treating T2D and CVD.
Jun 21, 2023
15 min
2023 Episode 8 - New Science from AHA Scientific Sessions 2022 - CVD Risk Management in Patients with T2D
This podcast highlights the new science presented at the American Heart Association’s (AHA’s) Scientific Sessions in 2022. Jane Reusch, MD, Nathan Wong, PhD, MPH, and Chiadi Ndumele, MD, PhD, MHS discuss clinical highlights related to CVD risk management in patients with diabetes, including renal disease, and how to incorporate these findings into clinical practice. 
Feb 7, 2023
35 min
2022 Episode 7 – Life’s Essential 8™
Help patients with diabetes manage their risk for heart disease and stroke. Donald Lloyd-Jones, MD, ScM, FAHA, FACC and Jane EB Reusch, MD, FAHA discuss the recent release of AHA’s Life’s Essential 8 which was expanded from Life’s Simple 7 to include healthy sleep for optimal cardiovascular health as well as other lifestyle factors included in Life’s Essential 8 and how health care professionals can use this checklist to help patients with diabetes manage their risk for heart disease and stroke.
Oct 4, 2022
33 min
2022 Episode 6 – Three Basic Targets
Diabetes is more than a blood sugar problem. Help your patients with type 2 diabetes understand their risk of cardiovascular disease and the importance of blood pressure, lipid, and glucose control in managing risk.  Listen to Nathan Wong, PhD, MPH and Colette Knight, MD discuss ways for patients to know and understand their numbers in LDL cholesterol, triglycerides, blood pressure, A1C, and more.  
Jul 27, 2022
39 min
2022 Episode 5 – Initiative Update
Listen to Eduardo Sanchez, MD, MPH, FAHA and Robert A. Gabbay, MD, PhD give an update on the initiative from launch through 2021 including notable insights, key learnings and future outlook as well as empowering patients to be active members of their health care team.
Mar 4, 2022
22 min
2021 Episode 4 - Diabetes and PAD: A Recipe for Amputation
Listen to Philip P. Goodney, MD, MS, Foluso A. Fakorede, MD and Peter A. Schneider, MD discuss the differences in preventive measures offered to patients with diabetes and peripheral artery disease (PAD) as well as better delivery of preventive measures to high-risk patients and high-risk regions in the United States.
Oct 28, 2021
37 min
2021 Episode 3 – Implementation of Guideline-Based Care in the Hospital Setting
Listen to Dr. Jennifer Green and Dr. Neha Pagidipati discuss the utilization of SGLT2i and GLP-1RA in the hospital setting in patients with indications for such therapy, as described in the 2021 ADA Standards of Medical Care and current AHA guidelines, including the recent ASA/AHA Recurrent Stroke prevention guidelines.
Sep 28, 2021
25 min
2021 Episode 2 – Metformin: Is it Always First?
Listen to George L. Bakris, MD, FAHA, FASN, Cecilia C. Low Wang, MD, FACP and Neda Rasouli, MD educate clinicians on the updates made in the 2021 ADA Standards of Care related to metformin use and considerations for when the guideline recommends considering use of SGLT-2 Inhibitors and GLP-1 receptor agonists independent of A1C or metformin use.
Jul 8, 2021
27 min
Load more